西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2014年
11期
53-55
,共3页
再生障碍性贫血,慢性%T淋巴细胞亚群%肿瘤坏死因子%白介素-3%健脾补肾活血汤
再生障礙性貧血,慢性%T淋巴細胞亞群%腫瘤壞死因子%白介素-3%健脾補腎活血湯
재생장애성빈혈,만성%T림파세포아군%종류배사인자%백개소-3%건비보신활혈탕
chronic aplastic anemia%T-lymphocyte subsets%tumor necrosis factor%interleukin-3%JianPi BuShen HuoXue decoction
目的:观察健脾补肾活血汤治疗慢性再生障碍性贫血(再障)的临床疗效。方法:将再障患者80例随机分为对照组、治疗组各40例。对照组采用司坦唑醇片联合环孢素A(CsA)治疗,治疗组在对照组基础上加用健脾补肾活血汤治疗,疗程6个月。观察2组患者临床疗效及治疗前后外周血T细胞亚群、外周血象、血清肿瘤坏死因子α(TNF-α)和白介素3(IL-3)的变化情况。结果:治疗组治疗后CD4升高、CD8降低、CD4/CD8升高;TNF-α降低,IL-3升高,与治疗前及对照组比较差异均有统计学意义(P<0.O5)。结论:健脾补肾活血汤可能通过改善T淋巴细胞亚群的比例,减少TNF-α造血负调控因子及增加IL-3造血正调控因子的释放,解除对骨髓造血的抑制,从而促进造血功能的恢复。
目的:觀察健脾補腎活血湯治療慢性再生障礙性貧血(再障)的臨床療效。方法:將再障患者80例隨機分為對照組、治療組各40例。對照組採用司坦唑醇片聯閤環孢素A(CsA)治療,治療組在對照組基礎上加用健脾補腎活血湯治療,療程6箇月。觀察2組患者臨床療效及治療前後外週血T細胞亞群、外週血象、血清腫瘤壞死因子α(TNF-α)和白介素3(IL-3)的變化情況。結果:治療組治療後CD4升高、CD8降低、CD4/CD8升高;TNF-α降低,IL-3升高,與治療前及對照組比較差異均有統計學意義(P<0.O5)。結論:健脾補腎活血湯可能通過改善T淋巴細胞亞群的比例,減少TNF-α造血負調控因子及增加IL-3造血正調控因子的釋放,解除對骨髓造血的抑製,從而促進造血功能的恢複。
목적:관찰건비보신활혈탕치료만성재생장애성빈혈(재장)적림상료효。방법:장재장환자80례수궤분위대조조、치료조각40례。대조조채용사탄서순편연합배포소A(CsA)치료,치료조재대조조기출상가용건비보신활혈탕치료,료정6개월。관찰2조환자림상료효급치료전후외주혈T세포아군、외주혈상、혈청종류배사인자α(TNF-α)화백개소3(IL-3)적변화정황。결과:치료조치료후CD4승고、CD8강저、CD4/CD8승고;TNF-α강저,IL-3승고,여치료전급대조조비교차이균유통계학의의(P<0.O5)。결론:건비보신활혈탕가능통과개선T림파세포아군적비례,감소TNF-α조혈부조공인자급증가IL-3조혈정조공인자적석방,해제대골수조혈적억제,종이촉진조혈공능적회복。
Objective: To observe curative effects of JianPi BuShen HuoXue decoction in treating chronic aplastic anemia (CAA). Methods:Eighty patients were randomized into the control group and the treatment group. The control group were treated by stanozolol tablets and ciclosporin A (CsA), and the treatment group JianPi BuShen HuoXue decoction on the foundation of the therapy given to the control group, one course of the treatment was six months. Therapeutic effects, the changes of T-lymphocyte subsets, peripheral blood, tumor necrosis factor-α(TNF-α) and interleukin-3 (IL-3) in both groups were observed. Results:CD4 was raised, CD8 decreased, CD4/CD8 increased;TNF-αlowered but IL-3 raised, the differences were significant when the treatment group after treating was compared with before treating or the control group (P<0.05). Conclusion:JianPi BuShen HuoXue decoction could promote the recovery of hemopoiesis, which might be realized by improving the ratio of T-lymphocyte sub-sets, reducing the release of negative regulating factor TNF-α, increasing positive regulating factor IL-3 and elimi-nating the inhibition of bone marrow hemopoiesis.